Laminar Wins Gold 2026 Edison Award for Physical AI that Powers the Self-Driving Factory
Top honor recognizes Laminar's innovation and transformation in the CPG manufacturing industryBOSTON,…
Mantle Unites Global AI, Tech, and Youth Communities for Its Largest AI Hackathon, Backed by Tencent Cloud, Bybit, Byreal, and Blockchain for Good Alliance
DUBAI, UAE, April 22, 2026 /PRNewswire/ -- Mantle, the premier distribution layer…
Aurise Foundation Launches XAUE, Unlocking Yield for RWA Gold
PANAMA CITY, April 22, 2026 /PRNewswire/ -- Aurise Foundation today announced the launch…
Google and HP Receive Frost & Sullivan’s 2026 Global New Product Innovation Recognition for Advancing 3D Video Communications and Human-Centric Collaboration
Recognized for breakthrough innovation in redefining video communications with immersive, lifelike experiences…
Brigade Electronics Receives Frost & Sullivan’s 2026 European Market Leadership Recognition in the Commercial Vehicle Safety Systems Industry for Excellence in Fleet-Wide Safety Technology Standardization
Brigade Electronics is a leading hardware-centric supplier for leveraging safety regulations and…
Apparel Group Strengthens Digital Footprint with the Launch of ALDO App for the Indian Market
Express Delivery, Curated Style & Seamless Digital Experience Now Live on Google…
Bybit AI Expands to Infrastructure Layer with Official MCP Release for Multi-Agent Trading
DUBAI, UAE, April 22, 2026 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange…
MetaComp launches the world’s first AI agent governance framework for regulated financial services
Introduced at Money20/20 Asia, the StableX Know Your Agent Framework establishes how…
Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting
Single-dose of miv-cel achieved robust and durable improvements in mobility, reversed disability…
Revolution Medicines to Present Updated Phase 1/2 Clinical Data for Daraxonrasib in First Line Metastatic Pancreatic Cancer Across Monotherapy and Combination Cohorts at the 2026 AACR Annual Meeting
REDWOOD CITY, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc.…
